Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Coccia

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Neurology|January 3, 2022
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersenSilvia Bonanno, Riccardo Zanin, Luca Bello, et al.
Journal of Neurology|June 3, 2024
Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patientsMario Sabatelli, Federica Cerri, Riccardo Zuccarino, et al.
Neuromuscular Disorders : NMD|November 9, 2023
Respiratory function in a large cohort of treatment-naïve adult spinal muscular atrophy patients: a cross-sectional studyAlex Vicino, Luca Bello, Silvia Bonanno, et al.
European Journal of Pediatrics|June 9, 2025
Italian validation of the SMA independence scale-upper limb moduleChiara Bravetti, Giorgia Coratti, Maria Carmela Pera, et al.
Journal of Neurology|November 19, 2025
Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patientsAlex Vicino, Antonio Lauletta, Silvia Bonanno, et al.
Annals of Neurology|September 11, 2023
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?Martina Ricci, Gianpaolo Cicala, Anna Capasso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3Lorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2022
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on diseaseLorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Neurology|December 2, 2022
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide SurveyGiorgia Coratti, Martina Ricci, Anna Capasso, et al.
Muscle & Nerve|August 3, 2024
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersenAlessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Neurology|January 3, 2022
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersenSilvia Bonanno, Riccardo Zanin, Luca Bello, et al.
Journal of Neurology|June 3, 2024
Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patientsMario Sabatelli, Federica Cerri, Riccardo Zuccarino, et al.
Neuromuscular Disorders : NMD|November 9, 2023
Respiratory function in a large cohort of treatment-naïve adult spinal muscular atrophy patients: a cross-sectional studyAlex Vicino, Luca Bello, Silvia Bonanno, et al.
European Journal of Pediatrics|June 9, 2025
Italian validation of the SMA independence scale-upper limb moduleChiara Bravetti, Giorgia Coratti, Maria Carmela Pera, et al.
Journal of Neurology|November 19, 2025
Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patientsAlex Vicino, Antonio Lauletta, Silvia Bonanno, et al.
Annals of Neurology|September 11, 2023
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?Martina Ricci, Gianpaolo Cicala, Anna Capasso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3Lorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2022
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on diseaseLorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Neurology|December 2, 2022
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide SurveyGiorgia Coratti, Martina Ricci, Anna Capasso, et al.
Muscle & Nerve|August 3, 2024
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersenAlessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Pageof 4